After two and a half years providing COVID-19 testing services to New England and beyond – including over 1.6 million tests – JAX’s Clinical Genomics Laboratory has suspended COVID-19 testing as of Friday, July 29, 2022, in alignment with the significant decrease in COVID-19 PCR testing demand. We will continue to monitor the pandemic and testing needs, and are prepared to reinstate testing services should demand increase. We are grateful to our community partners for supporting and collaborating with the JAX CLIA lab on this important endeavor.
While testing and sequencing services are no longer JAX’s focus at present, we are continuing our vital COVID-19 research, including the investigating the biological complexities of COVID, long COVID, and developing mouse models for the study of this virus.
The JAX CLIA lab’s focus has now returned to serving the oncology community with complex tumor profiling assays that help cancer patients and their physicians learn about specific tumors and provide insight into the most promising treatment options. We are proud of the continued role we play in improving human health and empowering the global biomedical community in our shared quest to improve human health.
The Hartford Business Journal has recognized JAX among its 2020 Health Care Heroes in the Innovation category, recognizing an organization that has made a positive advancement in medical care or medical science.
Dr. Mark Adams of JAX and Dr. Nathan Grubaugh of the Yale School of Public Health spoke to legislators about how COVID s being monitored, which variants are present to date, and what we know about how the mutations are changing the properties of the virus itself.
Chia-Lin Wei looked at SARS-CoV-2 RNA genomes and sub-genomic viral RNA in symptomatic and asymptomatic patients and found distinct, consistent differences between the patient groups. The findings have important implications for developing better COVID-19 risk mitigation and clinical strategies.
The Jackson Laboratory’s clinical testing lab in Farmington, Conn., has processed an astonishing 1.5 million COVID-19 tests since March 2020. That quantity is backed up by quality: The College of American Pathologists (CAP) has renewed its accreditation of the lab, following an inspection with a perfect score.